Michael K Schultz PhD

Professor Michael K Schultz, PhD, is applying his expertise to address challenges in the field of radiology and oncology at the University of Iowa. As an Associate Professor of Radiology, Pediatrics, Chemistry, and Radiation Oncology, he is dedicated to advancing the understanding and treatment of cancer through innovative research. His work is particularly focused on the development of image-guided radionuclide-based therapies, which hold promise for more precise and effective cancer treatments. Dr. Schultz's research is centered on the creation of novel radiopharmaceuticals aimed at targeting neuroendocrine tumors (NETs) and related pediatric brain tumors. By developing these targeted therapies, he aims to improve the specificity and efficacy of cancer treatments, potentially leading to better outcomes for patients. His involvement with the NET SPORE, under the leadership of M. Sue O’Dorisio MD PhD, further underscores his commitment to advancing research in this critical area. In addition to his work on radiopharmaceuticals, Dr. Schultz is also pioneering new methods for dosimetry of alpha particle emitters within the tumor microenvironment. This aspect of his research is crucial for understanding how these potent particles can be used safely and effectively to destroy cancer cells while minimizing damage to surrounding healthy tissue. His efforts in this area are contributing to the development of more precise and personalized cancer therapies. Through his multidisciplinary approach, Dr. Schultz is making significant strides in the field of cancer research. His work not only enhances our understanding of how to target and treat tumors more effectively but also paves the way for future innovations in radiopharmaceuticals and radionuclide-based therapies. As a dedicated researcher and educator, he continues to inspire and lead the next generation of scientists in the pursuit of breakthroughs in cancer treatment.